Literature DB >> 2895365

In-vitro production of HIV-specific antibody in children at risk of AIDS.

A Amadori1, A de Rossi, C Giaquinto, G Faulkner-Valle, F Zacchello, L Chieco-Bianchi.   

Abstract

To improve on the early diagnosis of human immunodeficiency virus (HIV) infection, 37 children born to HIV-infected mothers and 22 controls were investigated for in-vitro synthesis of IgG antibody directed against HIV components. For 14 of 16 infected children western blot showed HIV-specific IgG in the supernatants of cultures of their peripheral blood lymphocyte cultures. HIV-specific IgG synthesis was detected in cultures from 4 out of 17 seropositive children aged under 15 months with no clinical or laboratory evidence of infection. No HIV-specific IgG production was observed in cultures from 4 uninfected children or 22 controls. The results show that the demonstration of in-vitro production of HIV-specific IgG may help in the early diagnosis of HIV infection in children.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--etiology; Age Factors; Antibodies; Biology; Child Health; Demographic Factors; Developed Countries; Diseases; Europe; Examinations And Diagnoses; Health; Hematological Effects; Hemic System; Hiv Infections; Immunity; Immunoglobulin Alterations; Immunologic Factors; Infant; Italy; Laboratory Examinations And Diagnoses; Mediterranean Countries; Physiology; Population; Population Characteristics; Pregnancy; Pregnancy Outcomes; Reproduction; Research Report; Southern Europe; Viral Diseases; Youth

Mesh:

Substances:

Year:  1988        PMID: 2895365     DOI: 10.1016/s0140-6736(88)91603-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Sexually transmitted diseases in children: HIV infection.

Authors:  J Y Mok
Journal:  Genitourin Med       Date:  1992-10

2.  How frequent and how early does the neurological involvement in HIV-positive children occur? Preliminary results of a prospective study.

Authors:  A M Laverda; P Cogo; A Condini; C Cattelan; C Giaquinto; S Cozzani; E Ruga; F Viero; A De Rossi; A Del Mistro
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

3.  Vertical transmission of HIV: a prospective study.

Authors:  J Y Mok; R A Hague; P L Yap; F D Hargreaves; J M Inglis; J M Whitelaw; C M Steel; O B Eden; S Rebus; J F Peutherer
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

4.  Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1.

Authors:  M C García Rodriguez; I Bates; I de José; F Hawkins; R Martinez-Zapico; A Ferreira; G Fontán
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

Review 5.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

6.  Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection.

Authors:  D Nadal; U A Hunziker; J Schüpbach; J C Wetzel; Z Tomasik; J B Jendis; A Fanconi; R A Seger
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.

Authors:  H Pollack; M X Zhan; T Ilmet-Moore; K Ajuang-Simbiri; K Krasinski; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection.

Authors:  J P Vendrell; M Segondy; J Ducos; J Reynes; M F Huguet; J C Nicolas; A Serre
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.

Authors:  A Shirai; M Cosentino; S F Leitman-Klinman; D M Klinman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.